INVESTORS & MEDIA
Corporate Governance
| Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Dec 16, 2016 |
EVP Commercial
Trans History: 172
|
EVP Commercial | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 34,000 | -- | 34,000 |
| Dec 16, 2016 |
EVP & General Mgr Industrial O
Trans History: 359
|
EVP & General Mgr Industrial O | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 34,000 | -- | 34,000 |
| Dec 16, 2014 |
SVP Finance & CFO
Trans History: 465
|
SVP Finance & CFO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 34,000 | -- | 34,000 |
| Dec 16, 2014 |
SVP General Counsel and Secret
Trans History: 181
|
SVP General Counsel and Secret | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 34,000 | -- | 34,000 |
| Dec 16, 2014 |
SVP Clinical Development & Reg
Trans History: 208
|
SVP Clinical Development & Reg | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 34,000 | -- | 34,000 |
| Sep 17, 2003 |
Director, EVP, CSO, & Pres Regn Res Labs
Trans History: 628
|
Director, EVP, CSO, & Pres Regn Res Labs | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 34,250 | -- | -- |
| Sep 17, 2003 |
Director, EVP, CSO, & Pres Regn Res Labs
Trans History: 628
|
Director, EVP, CSO, & Pres Regn Res Labs | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 34,250 | $4.25 | 92,836 |
| Sep 06, 2011 |
SVP Research and Development S
Trans History: 660
|
SVP Research and Development S | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 34,399 | $65.76 | 84,110 |
| Mar 17, 2014 |
Ten Percent Owner
Trans History: 555
|
Ten Percent Owner | Form 4 | Open market or private purchase of non-derivative or derivative security | 34,499 | $328.32 | 18,084,918 |
| Nov 20, 2007 |
VP, Regul Devel & Clin Safety
Trans History: 288
|
VP, Regul Devel & Clin Safety | Form 4 | Bona fide gift | 34,684 | -- | 34,684 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.